Respiratory syncytial virus (RSV) vaccination and higher antibody concentration were associated with reduced RSV infection risk in older adults in an observational cohort study, from University of Michigan and MCIDT researchers.
Key Terms: Respiratory syncytial virus; Vaccine effectiveness; Correlates of protection; Antibody waning; Cohort study; Older adults
